Cluster Headache Clinical Trial
Official title:
Noninvasive Vagus Nerve Stimulation for the Prevention and Treatment of Primary Headache: a Randomized, Double-blind, Single-center Clinical Trial.
This study is a single-center, randomized, double-blind controlled study. Patients will be randomly assigned to two groups by envelope drawing. The subjects will be divided into two groups: the acute intervention group and the preventive intervention group. In each group, the subjects will be randomly divided into the experimental group and the control group by means of envelope extraction. Children and adolescents (7-20 years old) with migraine who met the inclusion criteria will be enrolled as subjects in the experimental group, and the changes in headache scores before and after the intervention will be compared. The intervention method is as follows: ictal intervention, in which subjects will be evaluated for headache improvement after a short intervention during an acute exacerbation. By wearing a vagus stimulator, the stimulating electrode will be located in the concha region rich in vagus nerve fiber endings, and the appropriate stimulation intensity will be adjusted for stimulation. Therefore, this study will verify the effect of nVNS on the acute attack and preventive treatment of primary headache in children and adolescents. Based on the electrocardiogram and electromyography indicators during the intervention process of nVNS, an objective evaluation system for the improvement of headache by nVNS is established, and the role of stimulation parameters on the effect is further explored to realize the optimization of parameters.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05264714 -
Cluster Headache Treatment With Rimegepant
|
Phase 2 | |
| Completed |
NCT01677026 -
Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache
|
||
| Terminated |
NCT00203190 -
A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache
|
Phase 4 | |
| Recruiting |
NCT04570475 -
High Dose Vitamin D Plus Multivitamin in the Prevention of Cluster Headache
|
Phase 3 | |
| Completed |
NCT04066023 -
Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT04353505 -
Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
|
Phase 1 | |
| Completed |
NCT02019017 -
Botox Injection in Treatment of Cluster Headache
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05153876 -
An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients
|
||
| Recruiting |
NCT05324748 -
Repeated GON Injections in CCH
|
Phase 3 | |
| Completed |
NCT02782533 -
DBS of the Third Ventricle for Cluster Headache and Obesity
|
N/A | |
| Completed |
NCT04179266 -
Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04406259 -
Atrioventricular Block and Cluster Headache (SEVA)
|
Phase 4 | |
| Recruiting |
NCT06206772 -
Resting State Functional Connectivity in Cluster Headache
|
||
| Recruiting |
NCT03944876 -
Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache
|
Phase 3 | |
| Not yet recruiting |
NCT05857098 -
Detection of Local Field Potentials in the Ventral Tegmental Area of the Midbrain in Chronic Cluster Headache Patients
|
||
| Recruiting |
NCT02910323 -
The Will Erwin Headache Research Center - Cluster Headache Study
|
||
| Terminated |
NCT00458770 -
Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks
|
N/A | |
| Completed |
NCT00662935 -
Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH)
|
N/A | |
| Active, not recruiting |
NCT03511846 -
Pain Biomarker Study
|
Phase 1 | |
| Completed |
NCT00184587 -
Prophylactic Treatment of Episodic Cluster Headache
|
Phase 2 |